ImmunityBio (IBRX) Cash & Current Investments (2014 - 2026)
ImmunityBio's Cash & Current Investments was $357.37 million in Q2 2026, up 132.6% from $153.66 million a year earlier but down 6.2% from the prior quarter.
Powered by 
Analysis
ImmunityBio (IBRX) Cash & Current Investments (2014 - 2026) Analysis & Trends
At the end of FY2025, Cash & Current Investments at ImmunityBio came in at $242.82 million, up 62.1% from FY2024.
- Cash & Current Investments shows a five-year compound annual growth rate of 20.4% (FY2020 to FY2025).
- In earlier years, Cash & Current Investments was $149.81 million in FY2024 (-43.8%), $266.46 million in FY2023 (+148.6%), $107.18 million in FY2022 (-66.2%) and $317.12 million in FY2021 (+230.1%).
- Quarterly Cash & Current Investments has moved between $45.95 million (Q2 2023) and $380.88 million (Q1 2026) over five years.
- Compared with a year earlier, Cash & Current Investments has increased for four straight quarters, with growth averaging 80.3% over the last eight quarters.
- The best year-over-year quarter for Cash & Current Investments over five years was Q1 2026 (growth of 518.4%); the worst was Q4 2022 (a decline of 66.2%).
- Per Business Quant data, IBRX's Cash & Current Investments in the three quarters before Q2 2026 was $380.88 million (Q1 2026), $242.82 million (Q4 2025) and $257.81 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.76 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 9.92 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.97 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.70 Bn |
| 10 | ImmunityBio | 10.83 Bn | 9.59 Bn | 50.94 Mn | 357.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 357.37 Mn |
| Mar 31, 2026 | 380.88 Mn |
| Dec 31, 2025 | 242.82 Mn |
| Sep 30, 2025 | 257.81 Mn |
| Jun 30, 2025 | 153.66 Mn |
| Mar 31, 2025 | 61.59 Mn |
| Dec 31, 2024 | 149.81 Mn |
| Sep 30, 2024 | 130.37 Mn |
| Jun 30, 2024 | 217.98 Mn |
| Mar 31, 2024 | 170.50 Mn |
| Dec 31, 2023 | 266.46 Mn |
| Sep 30, 2023 | 189.80 Mn |
| Jun 30, 2023 | 45.95 Mn |
| Mar 31, 2023 | 91.27 Mn |
| Dec 31, 2022 | 107.18 Mn |
| Sep 30, 2022 | 111.06 Mn |
| Jun 30, 2022 | 82.94 Mn |
| Mar 31, 2022 | 192.33 Mn |
| Dec 31, 2021 | 317.12 Mn |
| Sep 30, 2021 | 80.37 Mn |
API Access
ImmunityBio Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IBRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "IBRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=IBRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();